Dr Sandra Le Quellec, MD PhD, is a dedicated haematologist and Associate Professor of Medicine at the University of Claude Bernard Lyon I, Lyon, France. She earned her medical degree and completed a 4-year haemostasis fellowship at both the Haemophilia Comprehensive Care Centre of Lyon, and the Laboratory of Haematology, Lyon, France. Meanwhile, she earned her PhD degree on gene therapy for haemophilia, for which she had worked in collaboration with two research laboratories: EA4609 – Haemostasis and Cancer (Prof. Claude Négrier) at the University Claude Bernard Lyon I, Lyon, France and the Research Laboratory of Haematology (Prof Amit Nathwani) at the University College of London, United Kingdom. Currently, she participates in the clinical care of patients with either bleeding or thrombotic disorders, she is responsible for the department of platelet function analyses in the laboratory of haematology. Her main research interest relies in the development of therapeutic options for haemophilia.

Assoc. Prof. Sandra Le Quellec has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Bayer, CSL Behring, LFB, Octopharma, Roche/Chugai, Sobi and Takeda.